Lê, H.; Seitlinger, J.; Lindner, V.; Olland, A.; Falcoz, P.-E.; Benkirane-Jessel, N.; Quéméneur, E.
Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine. Biomedicines 2022, 10, 1677.
https://doi.org/10.3390/biomedicines10071677
AMA Style
Lê H, Seitlinger J, Lindner V, Olland A, Falcoz P-E, Benkirane-Jessel N, Quéméneur E.
Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine. Biomedicines. 2022; 10(7):1677.
https://doi.org/10.3390/biomedicines10071677
Chicago/Turabian Style
Lê, Hélène, Joseph Seitlinger, Véronique Lindner, Anne Olland, Pierre-Emmanuel Falcoz, Nadia Benkirane-Jessel, and Eric Quéméneur.
2022. "Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine" Biomedicines 10, no. 7: 1677.
https://doi.org/10.3390/biomedicines10071677
APA Style
Lê, H., Seitlinger, J., Lindner, V., Olland, A., Falcoz, P.-E., Benkirane-Jessel, N., & Quéméneur, E.
(2022). Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine. Biomedicines, 10(7), 1677.
https://doi.org/10.3390/biomedicines10071677
